The scientist’s investigation covers issues in Adenosine receptor, Adenosine, Receptor, Internal medicine and Endocrinology. His Adenosine receptor study frequently intersects with other fields, such as Molecular biology. His Adenosine research incorporates themes from Mechanism of action, Agonist, Immunology, Cell biology and Heart rate.
His work in Agonist tackles topics such as Enzyme inhibitor which are related to areas like Stereochemistry and Protein kinase A. His Receptor research integrates issues from Signal transduction, Pharmacology and Kidney metabolism. In his research on the topic of Adenosine A2B receptor, Adenosine A3 Receptor Agonists, Xanthine and Chinese hamster ovary cell is strongly related with Adenosine A3 Receptor Antagonists.
Adenosine receptor, Adenosine, Receptor, Internal medicine and Endocrinology are his primary areas of study. His research integrates issues of Stereochemistry and Pharmacology in his study of Adenosine receptor. His studies in Adenosine integrate themes in fields like Adenosine A1 receptor, Immunology, Ischemia, Cell biology and Adenosine A2A receptor.
His studies deal with areas such as Molecular biology and Xanthine as well as Receptor. His Agonist research incorporates elements of Reperfusion injury and Anesthesia. His work deals with themes such as Adenosine A2B receptor and Purinergic signalling, which intersect with Adenosine A3 receptor.
His primary scientific interests are in Adenosine, Immunology, Receptor, Internal medicine and Cell biology. His Adenosine research includes elements of Agonist, Adenosine A3 receptor, Adenosine A2B receptor, Adenosine receptor and Immune system. He combines subjects such as Neuroscience and Inosine with his study of Adenosine receptor.
His Immunology study combines topics from a wide range of disciplines, such as Reperfusion injury and Pharmacology. His Receptor study deals with the bigger picture of Biochemistry. Joel Linden interconnects Endocrinology and Type 2 diabetes in the investigation of issues within Internal medicine.
His primary areas of investigation include Adenosine, Cell biology, Receptor, Natural killer T cell and Purinergic signalling. Joel Linden has included themes like Adenosine A2B receptor, Pharmacology and Pneumonia in his Adenosine study. His work carried out in the field of Cell biology brings together such families of science as T cell and Cell.
Joel Linden specializes in Receptor, namely Adenosine receptor. The concepts of his Purinergic signalling study are interwoven with issues in Adenosine A1 receptor, Adenosine A3 receptor, Signal transduction and Paracrine signalling. Joel Linden focuses mostly in the field of Adenosine A1 receptor, narrowing it down to topics relating to Motility and, in certain cases, Endocrinology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Bertil B. Fredholm;Adriaan P. IJzerman;Kenneth A. Jacobson;Karl-Norbert Klotz.
Pharmacological Reviews (2001)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio;Karen M. Dwyer;Wenda Gao;David J Friedman.
Journal of Experimental Medicine (2007)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
Bertil B. Fredholm;Adriaan P. IJzerman;Kenneth A. Jacobson;Joel Linden.
Pharmacological Reviews (2011)
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
György Haskó;Joel Linden;Bruce Cronstein;Pál Pacher.
Nature Reviews Drug Discovery (2006)
The cardiac effects of adenosine
Luiz Belardinelli;Luiz Belardinelli;Joel Linden;Joel Linden;Robert M. Berne;Robert M. Berne.
Progress in Cardiovascular Diseases (1989)
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Annual Review of Pharmacology and Toxicology (2001)
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Paul E. Zarek;Ching Tai Huang;Eric R. Lutz;Jeanne Kowalski.
Molecular cloning and characterization of the human A3 adenosine receptor
Christopher A. Salvatore;Marlene A. Jacobson;Heidi E. Taylor;Joel Linden.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.
Trends in Pharmacological Sciences (1994)
Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system.
Diane L. Rosin;Anna Robeva;Robin L. Woodard;Patrice G. Guyenet.
The Journal of Comparative Neurology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: